MAINSTREAM MEDIA AND PUBLIC HEALTH TURN ON BIG PHARMA
By Byron J. Richards, CCN
January 31, 2011
Wonders never cease. The blatant poisoning of individuals under the false pretense of health could soon be coming to an end. A series of studies published this month by mainstream researchers, issued in mainstream journals, and even carried in mainstream media is signaling the beginning of the end of the Big Pharma PR drug-sales juggernaut. The two top-selling drug classes have come under direct attack and public health officials are proclaiming that Big Pharma marketing is causing far more damage then benefit to the health of Americans – at incredible cost to taxpayers. The Big Pharma house of cards is poised for collapse.
Heading the onslaught were a number of studies attacking Big Pharma’s sacred cow – the extensive over-marketing of statin drugs to lower cholesterol. Shockingly, mainstream media—who is paid big money by Big Pharma—is running headlines like this, Statins: Bad Idea for People with Good Hearts? At risk is ten billion in fraudulent drug sales every year.
The CBS article above was generated in response to a press release and article published by the Cochrane Library. The article sought to establish the cost effectiveness of individuals with high cholesterol but no prior history of a heart attack, taking statins to prevent a first heart attack. This type of patient is now the big push for new statin sales – along with a PR campaign trying to convince us that statins are so good they should be in the drinking water.